ESPL1 and sarcoma: We failed to observe any tumors or any other obvious abnormalities in the ESPL1+/hyp mice during their life span though about 5% of the control cohort of littermate WT mice developed sarcomas and appeared sick (possible lymphomas) and had to be sacrificed within a 2 year time frame.